# Vaccine Therapy Following Chemotherapy & Peripheral Stem Cell Transplantation in Treating Non-Hodgkin's Lymphoma

> **NCT00006478** · PHASE2 · TERMINATED · sponsor: **University of Nebraska** · enrollment: 19 (actual)

## Conditions studied

- Lymphoma

## Interventions

- **BIOLOGICAL:** autologous tumor cell vaccine
- **BIOLOGICAL:** keyhole limpet hemocyanin
- **BIOLOGICAL:** sargramostim
- **PROCEDURE:** adjuvant therapy

## Key facts

- **NCT ID:** NCT00006478
- **Lead sponsor:** University of Nebraska
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2000-10-11
- **Primary completion:** 2008-04-03
- **Final completion:** 2008-04-03
- **Target enrollment:** 19 (ACTUAL)
- **Why stopped:** Genitope suspend drug development by decision made by the FDA March 6, 2008.
- **Last updated:** 2023-09-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00006478

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00006478, "Vaccine Therapy Following Chemotherapy & Peripheral Stem Cell Transplantation in Treating Non-Hodgkin's Lymphoma". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT00006478. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*